Find a Product

News & Press Releases





1/5/2016
Rapidly Develop Drugs Targeting Interleukins with New PathHunter® Cell-Based Assays from DiscoverX

PathHunter® portfolio expansion with Interleukin cell-based assays

5/21/2014
DiscoverX Enables Predictive In Vitro Drug Combination Studies with launch of BioMAP® Combo ELECT

Primary Human Cell Models Identify Potential Safe and Efficacious Drug Combinations

4/4/2014
DiscoverX Platforms for Phenotypic and Target Based Screening Provide Unique Tools for Cancer Therapeutic Discovery

Primary Human Cell and Co-Culture Assay Systems for Oncology Highly Predictive of Drug Activity in<br /> Relation to Inflammation, Neo-Vascularization and Tumor Microenvironments<br /> <br /> Capabilities for Cancer Drug Discovery Highlighted in &lsquo;Advanced Drug Delivery Reviews&rsquo; Publication<br /> and American Association of Cancer Research 2014 Meeting Presentations<br /> &nbsp;

3/19/2014
DiscoverX to Highlight Capabilities of BioMAP® Platform for Investigative Toxicology and Safety Assessment at Society of Toxicology Meeting

Activities Include a Complimentary Workshop on Analysis of Failed Pharmaceutical Compounds Profiled in Primary Human Cell Systems Using BioMAP<sup>&reg;</sup>

3/5/2014
Research by Structural Genomics Consortium and DiscoveRx Points to New Multi-Targeting Approaches to Cancer Therapy

Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins

Displaying results 11-20 (of 42)
 |<  <  1 - 2 - 3 - 4 - 5  >  >|